Tauriga Sciences, Inc. Share Price Other OTC
Equities
TAUG
US87669X2053
Pharmaceuticals
Sales 2020 | 0.23 19.54 | Sales 2021 | 0.29 23.79 | Capitalization | 29.3M 2.44B |
---|---|---|---|---|---|
Net income 2020 | -3M -250M | Net income 2021 | -3M -250M | EV / Sales 2020 | 1,59,01,203 x |
Net Debt 2020 | 373K 31.14M | Net cash position 2021 | 1.04M 86.63M | EV / Sales 2021 | 9,90,58,952 x |
P/E ratio 2020 |
-0.87
x | P/E ratio 2021 |
-6.09
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Seth M. Shaw
CEO | Chief Executive Officer | 45 | 22/12/22 |
Kevin P. Lacey
DFI | Director of Finance/CFO | 55 | 05/17/05 |
Keith A. Aqua
CTO | Chief Tech/Sci/R&D Officer | - | 15/20/15 |
Members of the board | Title | Age | Since |
---|---|---|---|
James V. Rosati
BRD | Director/Board Member | 74 | 08/21/08 |
Seth M. Shaw
CEO | Chief Executive Officer | 45 | 22/12/22 |
Director/Board Member | 46 | 08/21/08 |
1st Jan change | Capi. | |
---|---|---|
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |